Aug 17, 2026 06:51AM
Aug 10, 2026 08:01AM
May 5, 2026 05:04PM
Jan 12, 2026 08:31AM
Dec 4, 2025 08:42AM
Dec 3, 2025 01:02PM
Dec 3, 2025 08:01AM Clene reports positive ALS biomarker data for CNM-Au8 drug candidate
Nov 20, 2025 09:11AM
Nov 14, 2025 07:06AM
Sep 26, 2025 08:50AM
Sep 10, 2025 08:52AM
Sep 5, 2025 06:48AM
Aug 18, 2025 06:41AM
Aug 14, 2025 04:40PM Clene (CLNN) Misses Q2 EPS by 78c
Jul 1, 2025 09:29AM
Jul 1, 2025 06:53AM
Jun 30, 2025 08:05AM
Jun 9, 2025 09:00AM
May 8, 2025 04:55PM
May 7, 2025 08:00AM
Apr 8, 2025 08:07AM Clene (CLNN) Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session
Mar 25, 2025 06:50AM
Mar 24, 2025 04:52PM
Mar 13, 2025 06:48AM
Mar 12, 2025 08:02AM
Feb 26, 2025 06:50AM
Feb 25, 2025 08:03AM
Jan 30, 2025 05:35PM Clene Inc. secures additional NIH grant funds for ALS therapy
Jan 24, 2025 04:15PM
Nov 22, 2024 06:55AM
Nov 14, 2024 07:11AM
Nov 13, 2024 04:42PM
Oct 10, 2024 06:18AM
Oct 4, 2024 06:46AM
Sep 30, 2024 08:30AM Clene (CLNN) Announces $7.3M Offering
Sep 17, 2024 06:57AM
Sep 16, 2024 08:32AM
Sep 10, 2024 07:04AM
Aug 7, 2024 06:48AM
Aug 6, 2024 08:02AM
Jul 9, 2024 08:01AM
Jun 24, 2024 06:37AM H.C. Wainwright Reiterates Buy Rating on Clene, Inc. (CLNN)
Jun 21, 2024 07:10AM

445,679 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All